Observational studyEuropean urology2014

Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma.

Alexander S Parker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.